ROCKWELL MEDICAL, INC.(RMTI)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

ROCKWELL MEDICAL, INC. (RMTI) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores RMTI at 26.8/100 on a 32-signal composite quality model, placing it at rank #2,610 of 2,962 stocks — the bottom half of the AI-ranked universe. RMTI scores in the top quartile across institutional flow (99.8). Areas of concern include revenue growth (6.7) and revenue scale (11.6), which score below median versus the broader universe. Shareholder dilution risk is elevated at 35.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), ROCKWELL MEDICAL, INC. reports quarterly revenue of $17.8M, net income of $-1.2M, an operating margin of -6.0%. Top institutional holders of RMTI by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, GEODE CAPITAL MANAGEMENT, RENAISSANCE TECHNOLOGIES, based on the most recent SEC filings. RMTI trades on the Nasdaq exchange and files with the SEC under CIK 1041024. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate RMTI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ROCKWELL MEDICAL, INC. directly from SEC EDGAR.